Fady Ibraham Malik - 07 Jan 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
07 Jan 2025
Net transactions value
-$77,440
Form type
4
Filing time
10 Jan 2025, 16:25:38 UTC
Previous filing
10 Dec 2024
Next filing
21 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $21,200 +2,000 +1.7% $10.60 118,071 07 Jan 2025 Direct
transaction CYTK Common Stock Sale $98,640 -2,000 -1.7% $49.32 116,071 07 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -2,000 -4.9% $0.000000 39,105 07 Jan 2025 Common Stock 2,000 $10.60 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).